Small Cap Voice

mPhase Technologies, Inc. President, Ram Mantravadi, called in to SmallCapVoice.com to discuss the Company business model and the markets they serve. Mantravadi detailed how XDSL not only survived the pandemic but excelled bringing on new clients like Nathan’s Famous Hot Dogs, McDonalds and more. mPhase turned profitable in 2020 and set the goal of annual revenue of $30 million.

The existing client base in the travel industry for Travel Buddhi, helped keep mPhase on a positive trajectory throughout 2020. In addition, Travel Buddhi is adding new agent customers signing each week. Matravadi sees an uptick in the travel industry as the pandemic winds down. He also noted that Travel Buddhi achieved the goal of developing multiple revenue streams, beginning with core recurring monthly subscription revenue and eventually adding transaction-based revenue.

mPhase is a technology driven, innovative development company that creates and commercializes products and applications that impact everyday people. The Company is assembling industry-leading teams specializing in artificial intelligence, machine learning, software, consumer engagement, and other advanced technologies. Additional information can be found at the mPhase website, www.mphasetech.com. Please follow us on twitter: @mPhase_Tech for the latest updates.

Q BioMed (OTCQB: QBIO) (“the Company”) CEO Denis Corin called in to SmallCapVoice.com to discuss the recent news and events for the Company.

Q BioMed (OTCQB: QBIO) (“the Company”) CEO Denis Corin called in to SmallCapVoice.com to discuss the recent news and events for the Company. The Company recently announced the initial commercial uptake of Strontium89, its FDA approved drug for the non-opioid treatment of metastatic cancer in the bone. Q BioMed announced the US-based launch of Strontium89 (Strontium Chloride Sr-89 Injection, USP), in Q1 of this year.

Q BioMed is deploying a robust multi-channel marketing campaign, driving awareness amongst its target audiences, both on the physician and the patient side. The Company will exhibit Strontium89 at several conferences including ASTRO (American Society of Therapeutic Radiation Oncology) and ONS (Oncology Nursing Society) and will begin speaker programs later this fall. Virtual and live sales calls have been ongoing since June within the confines of COVID-19 access and expanded field force efforts are planned for Q4 2020.

In other news, QBIO announced a COVID-19 clinical trial planned for Q1 2021 supported by Canadian Government. Proof of concept would validate platform for multiple indications and therapeutic alternatives in infectious diseases and others.

Q BioMed CEO Denis Corin stated, “This program is advancing very rapidly. We are very pleased with the input and support from government institutions and other industry stakeholders. There has been much talk of vaccines, but treatments are always going to be needed for people affected by these types of diseases, whether it’s SARS-Cov-2 or another pathogen resulting in similar symptoms and complications. The Mannin Tie2 platform is designed to address life threatening complications from a number of infectious diseases, including future potential viral threats. With the support of regulators we expect this treatment to be in the clinic very early next year.”

Jason Tucker, CEO of Strategic Asset Leasing Inc., is Featured in a New Interview at SmallCapVoice.com

Jason Tucker, CEO of Strategic Asset Leasing Inc., is Featured in a New Interview at SmallCapVoice.com. Tucker called in to SmallCapvoice.com, Inc. to go over the business model and markets served by his Company. In addition, Tucker provided his personal comments on the

milestones reached in 2020, recent news and upcoming events for the Company. LEAS recently announced announce a joint venture (JV) agreement with Electric Tribe, LLC. Electric Tribe has significant project experience in the nascent cannabis sector and will be working with LEAS to develop applications for contactless compliance protocols.

In the interview, Tucker provided details on how the Company is entering the cannabis tech markets though its JV with Electric Tribe, LLC, how LEAS will focus on the California market first before expanding into other states and the goals he has for becoming an established player is this burgeoning marketplace.

About Strategic Asset Leasing Inc.

LEAS is focused on leveraging technology assets with an initial focus on the Fintech industry and the Internet of Things (IOT). The “Internet of Things”, simply put, are devices and objects that also have an online connection such as personal voice assistants, smart home systems, video doorbells etc. These are rapidly growing sectors and LEAS will be developing and licensing technologies that will help companies penetrate these markets, thereby increasing shareholder value.

Michael Mo and Dave Harden Discuss Upcoming Events and Opportunities for KULR Technology Group, Inc. Within both the Commercial and National Security Verticals

Former Chief of Strategic Prioritization at the Pentagon, Dave Harden, elaborates on his illustrious career with Pentagon and U.S. Air Force and how his past work will assist KULR secure more contracts for its advanced thermal management capabilities.

In the interview Dave Harden stated, “The DOD (Department of Defense), over the past few years, has really put more of an emphasis on dual-use technologies like KULR’s advanced thermal management capabilities. In the 1950’s and 60’s it use the be that three dollars of research money came out of the DOD for every dollar that came out of the private sector for research and that’s flipped now. Companies like KULR need a sort of interpreter to navigate this new landscape.” He continued, “One of the big breakthroughs is the reinvention over the last few years of the SBIR (small business innovation research) grant. The SBIR is hundreds of millions of dollars set aside for small businesses to be fast tracked and receive non-dilutive capital. Through our combined efforts, KULR is now on that track. By winning a Phase 1 SBIR, KULR is now officially partners with the U.S. Air Force. Currently we have KULR submitted for a Phase 2 SBIR which will potentially be rewarded later this year for $750,000. This will really help KULR move to the next step in the Aerospace and Defense sectors.”

KULR Technology Group, Inc. (OTCQB: KULR) develops, manufactures and licenses next-generation carbon fiber thermal management technologies for batteries and electronic systems. Leveraging the company’s roots in developing breakthrough cooling solutions for NASA space missions and backed by a strong intellectual property portfolio, KULR enables leading aerospace, electronics, energy storage, 5G infrastructure, and electric vehicle manufacturers to make their products cooler, lighter and safer for the consumer. For more information, please visit www.kulrtechnology.com.

Verus CEO Anshu Bhatnagar describes the Company's business model, the markets they operate in, the management team and much more in a new audio interview.

Speaking with SCV’s Stuart Smith, Anshu Bhatnagar explains Verus International’s business model and focus on being an emerging multi-line consumer packaged goods (CPG) company developing branded product lines in the U.S. and on a global basis. He details on how Verus is expanding on a international level, adding new licensing agreements with the NHL adding to their existing MLB licensing agreements expanding their team with the addition of Andy Dhruv to the newly-created role of President of Verus Foods (Americas), and much more.

Verus is a global, emerging multi-line consumer packaged goods (CPG) company developing branded product lines in the U.S. and on a global basis. The Company trades on the OTC market (OTCQB: VRUS). Investors can find real-time quotes and market information for the Company on www.otcmarkets.com. Additional information is also available at the Company’s website, www.verusfoods.com, and via the official Twitter feed @Verus_Foods, the Big League Foods subsidiary Twitter feed @BigLeagueFoods and the Pachyderm Labs subsidiary Twitter feed @PachydermLabs.

Allstar Health Brands, Inc. CEO Discusses Recent News and Covid-19 Testing Efforts in a New Audio Interview with SmallCapVoice.com